{
  "url": "https://openlegislation.uk/eu-regulation-1994-2701/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-1994-2701/annex.json",
  "legislation": "eur/1994/2701",
  "legislation_title": "Commission Regulation (EC) No 2701/94 of 7 November 1994 amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-1994-2701",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "ANNEX I\nList of pharmacologically active substances for which maximum residue limits have been fixed\n1.. Anti-infectious agents\n1.1. Chemotherapeutics\n1.1.1. Sulfonamides\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\nAll substances belonging to the sulfonamide group\nParent drug\nAll food producing species\n100 μg/kg\nMuscle, liver, kidney, fat\nThe combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg\n1.2. Antibiotics\n1.2.1. Penicillins\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n1.2.1.1.\nBenzylpenicillin\nBenzylpenicillin\nAll food producing species\n50 μg/kg\nMuscle, liver, kidney, fat\n4 μg/kg\nMilk\n1.2.1.2.\nAmpicillin\nAmpicillin\nAll food producing species\n50 μg/kg\nMuscle, liver, kidney, fat\n4 μg/kg\nMilk\n1.2.1.3.\nAmoxicillin\nAmoxicillin\nAll food producing species\n50 μg/kg\nMuscle, liver, kidney, fat\n4 μg/kg\nMilk\n1.2.1.4.\nOxacillin\nOxacillin\nAll food producing species\n300 μg/kg\nMuscle, liver, kidney, fat\n30 μg/kg\nMilk\n1.2.1.5.\nCloxacillin\nCloxacillin\nAll food producing species\n300 μg/kg\nMuscle, liver, kidney, fat\n30 μg/kg\nMilk\n1.2.1.6.\nDicloxacillin\nDicloxacillin\nAll food producing species\n300 μg/kg\nMuscle, liver, kidney, fat\n30 μg/kg\nMilk\n1.2.2. Cephalosporins\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n1.2.2.1.\nCefquinome\nCefquinome\nBovine\n200 μg/kg\nKidney\n100 μg/kg\nLiver\n50 μg/kg\nMuscle\n50 μg/kg\nFat\n1.2.3. Quinolones\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n1.2.3.1.\nEnrofloxacin\nSum of enrofloxacin and ciprofloxacin\nBovine, porcine, poultry\n30 μg/kg\nMuscle, liver, kidney\n1.2.4. Macrolides\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n1.2.4.1. Tilmicosin\nTilmicosin\nBovine\n1 000 μg/kg\nLiver, kidney\n50 μg/kg\nMuscle, fat\n2.. Antiparasitic agents\n2.1. Agents acting against endoparasites\n2.1.1. Avermectins\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n2.1.1.1.\nIvermectin\n22,23- Dihydroavermectin B1a\nBovine\n100 μg/kg\nLiver\n40 μg/kg\nFat\nPorcine\n15 μg/kg\nLiver\nOvine\n20 μg/kg\nFat\nEquidae\n2.1.1.2.\nAbamectin\nAvermectin B1a\nBovine\n20 μg/kg\nLiver\n10 μg/kg\nFat\n2.1.1.3.\nDoramectin\nDoramectin\nBovine\n15 μg/kg\nLiver\n25 μg/kg\nFat\n2.1.2 Salicylanilides\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n2.1.2.1.\nClosantel\nClosantel\nBovine\n1 000 μg/kg\nMuscle, liver\n3 000 μg/kg\nKidney, fat\nOvine\n1 500 μg/kg\nMuscle, liver\n5 000 μg/kg\nKidney, fat\n2 000 μg/kg\nANNEX II\nList of substances not subject to maximum residue limits\n1.. Inorganic chemicals\nPharmacologically active substance(s)\nAnimal species\nOther provisions\n1.1.\nHydrogen peroxide\nFish\n1.2.\nSulphur\nBovine\nPorcine\nOvine\nCaprine\nEquidae\n1.3.\nIodine and iodine inorganic compounds including:\nSodium and potassium — iodide\nSodium and potassium — iodate\nIodophors including polyvinylpyrrolidone — iodine\nAll food producing species\n1.4.\nSodium chlorite\nBovine\nFor tropical use only\n2.. Organic compounds\nPharmacologically active substance(s)\nAnimal species\nOthers provisions\n2.1.\nEtiproston tromethamine\nBovine\nPorcine\n2.2.\nKetanserin tartrate\nEquidae\n2.3.\nFertirelin acetate\nBovine\n2.4.\nHuman menopausal urinary gonadotrophin\nBovine\n2.5.\nLactic acid\nAll food producing species\n2.6.\nMelatonin\nOvine\nCaprine\n2.7.\nIodine organic compounds\nIodoform\nAll food producing species\n2.8.\nAcetyl cysteine\nAll food producing species\nANNEX III\nList of pharmacologically active substances used in veterinary medicinal products for which provisional maximum residue limits have been fixed\n1.. Anti-infectious agents\n1.1. Chemotherapeutics\n1.1.1. Sulfonamides\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\nAll substances belonging to the sulfonamide group\nParent drug\nBovine, ovine, caprine\n100 μg/kg\nMilk\nProvisional MRL expires on 1. 1. 1996. The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg\n1.1.2. Diamino pyrimidine derivates\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n1.1.2.1.\nTrimethoprim\nTrimethoprim\nAll food producing species\n50 μg/kg\nMuscle, liver, kidney, fat, milk\nProvisional MRL expires on 1. 1. 1996\n1.1.3. Nitrofurans\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n1.1.3.1.\nFurazolidone\nAll residues with intact 5-nitro structure\nAll food producing species\n5 μg/kg\nMuscle, liver, kidney, fat\nProvisional MRL expires on 1. 7. 1995\n1.1.4. Nitroimidazoles\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n1.1.4.1.\nDimetridazole\nAll residues with intact nitroimidazole structure\nAll food producing species\n10 μg/kg\nMuscle, liver, kidney, fat\nProvisional MRL expires on 1. 1. 1995\n1.2. Antibiotics\n1.2.1. Tetracyclines\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\nAll substances belonging to the tetracycline group\nParent drug\nAll food producing species\n600 μg/kg\nKidney\nProvisional MRLs expire on 1. 1. 1996. The combined total residues of all substances within the tetracycline group should not exceed the limits indicated\n300 μg/kg\nLiver\n200 μg/kg\nEggs\n100 μg/kg\nMuscle\n100 μg/kg\nMilk\n1.2.2. Macrolides\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n1.2.2.1.\nSpiramycin\nSpiramycin\nBovine, porcine\n300 μg/kg\nLiver,\nProvisional MRLs expire on 1. 7. 1995. The MRLs for liver, kidney and muscle apply to both the bovine and porcine species\n200 μg/kg\nKidney,\n50 μg/kg\nMuscle\nBovine\n150 μg/kg\nMilk\n1.2.2.2.\nTylosin\nBovine\n100 μg/kg\nMuscle, liver, kidney\nProvisional MRLs expire on 1. 7. 1995\nPorcine\nPoultry\nBovine\n50 μg/kg\nMilk\n1.2.3. Thiamphenicol and related compounds\nPharmacologically active substance(s)\nMarket residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n1.2.3.1.\nThiamphenicol\nThiamphenicol\nBovine\nPoultry\n40 μg/kg\nMuscle, liver, kidney, fat\nProvisional MRL expires on 1. 1. 1996\n2.. Antiparasitic agents\n2.1. Agents acting against endo-parasites\n2.1.1. Benzimidazoles and pro-benzimidazoles\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n2.1.1.1.\nFebantel\nCombined residues of oxfendazole, oxfendazole sulfone and fenbendazole\nAll food producing species\n1 000 μg/kg\nLiver\nProvisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole\n10 μg/kg\nMuscle, kidney, fat\n10 μg/kg\nMilk\n2.1.1.2.\nFenbendazole\nCombined residues of oxfendazole, oxfendazole sulfone and fenbendazole\nAll food producing species\n1 000 μg/kg\nLiver\nProvisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole\n10 μg/kg\nMuscle, kidney, fat\n10 μg/kg\nMilk\n2.1.1.3.\nOxfendazole\nCombined residues of oxfendazole, oxfendazole sulfone and fenbendazole\nAll food producing species\n1 000 μg/kg\nLiver\nProvisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole\n10 μg/kg\nMuscle, kidney, fat\n10 μg/kg\nMilk\n2.1.1.4.\nAlbendazole\nSum of albendazole and metabolites which are measured as 2-amino-benzimidazole sulphone\nBovine\n100 μg/kg\nMuscle, fat, milk,\nProvisional MRLs expire on 1. 1. 1996\nOvine\n500 μg/kg\nKidney\n1 000 μg/kg\nLiver\n2.1.1.5.\nThiabendazole\nSum of thiabendazole and 5-hydroxythiabendazole\nBovine\n100 μg/kg\nMuscle, liver, kidney, fat, milk\nProvisional MRLs expire on 1. 1. 1996\nOvine\nCaprine\n2.1.1.6.\nTriclabendazole\nSum of extractable residues that may be oxidized to ketotriclabendazole\nBovine\n150 μg/kg\nMuscle, liver, kidney\nProvisional MRLs expire on 1. 7. 1995\nOvine\n50 μg/kg\nFat\n2.1.1.7.\nFlubendazole\nFlubendazole\nPoultry\n500 μg/kg\nLiver,\nProvisional MRLs expire on 1. 1. 1996\nGame birds\n200 μg/kg\nMuscle,\n400 μg/kg\nEggs\nPorcine\n10 μg/kg\nMuscle, liver, kidney, fat\n2.1.1.8.\nOxibendazole\nOxibendazole\nBovine\nOvine\n100 μg/kg\nMuscle, liver, kidney, fat\nProvisional MRLs expire on 1. 1. 1996\n50 μg/kg\nMilk\nPorcine\nEquidae\n100 μg/kg\nMuscle, liver, kidney, fat\n2.1.2. Tetra-hydro-imidazoles (imidazolthiazoles)\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n2.1.2.1.\nLevamisole\nLevamisole\nAll food producing species\n10 μg/kg\nMusle, liver, kidney, fat, milk\nProvisional MRL expires on 1. 1. 1995\n2.2. Agents acting against ectoparasites\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n2.2.1.\nAmitraz\nSum of amitraz and metabolites which are measured as 2,4-dimethylaniline\nPorcine\n50 μg/kg\nMuscle\nProvisional MRLs expire on 1. 7. 1996.\n200 μg/kg\nKidney, liver\n3.. Agents acting on the nervous system\n3.1. Agents acting on the central nervous system\n3.1.1. Butyrophenone tranquilizers\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n3.1.1.1.\nAzaperone\nAzaperol\nAll food producing species\n100 μg/kg\nKidney\nProvisional MRLs expire on 1. 1. 1996\n50 μg/kg1\nLiver, muscle, fat\n3.2. Agents acting on the autonomic nervous system\n3.2.1. Anti-adrenergics\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n3.2.1.1.\nCarazolol\nCarazolol\nAll food producing species\n30 μg/kg\nLiver\nProvisional MRLs expire on 1. 7. 1995\n5 μg/kg\nKidney, muscle, fat\nANNEX IV\nList of pharmacologically active substances for which no maximum levels can be fixed\n1.. Nitrofurans, except furazolidone (see Annex III)\n2.. Ronidazole\n3.. Dapsone\n4.. Chloramphenicol",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/1994/2701/annex",
    "retrieved_at": "2026-11-01T14:59:58.618860+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}